Research Article
Analysis of Clinical Manifestations and Imaging of COVID-19 Patients in Intensive Care
Table 1
Clinical feature analysis results of 61 COVID-19 patients.
| Characteristics | n | Ratio (%) |
| Symptoms | Epidemiological exposure | 47 | 77.0 | Fever | 61 | 100.0 | Cough | 56 | 91.8 | Shortness of breath | 48 | 78.7 | Muscle soreness | 40 | 65.6 | Diarrhea/vomiting | 8 | 13.1 | Headache | 4 | 6.6 |
| Course of disease | ≤7 d | 15 | 24.6 | 8–14 d | 23 | 37.7 | >14 d | 23 | 37.7 |
| Medicine treatment | Chinese herb | 61 | 100.0 | Abidor | 3 | 4.9 | Ribavirin | 8 | 13.0 | Glucocorticoids | 10 | 16.0 | Antipyretics | 57 | 93.0 | Antibiotics | 28 | 45.9 | Oseltamivir | 15 | 115.8 |
| Laboratory examination | WBC count | Normal | 40 | 57.7 | Higher | 9 | 15.4 | Lower | 12 | 26.9 | Lymphocyte count | Decreased | 53 | 86.9 | CRP | Increased | 29 | 47.5 | PCT | Increased | 15 | 24.6 | ESR | Increased | 38 | 62.3 | D-dimer | 39 | 63.9 | ALT/AST | 40 | 65.6 | CK/CK-MB | Increased | 8 | 13.1 | Troponin I | Increased | 6 | 9.8 | NT-proBNP | 35 | 57.4 | IL-1 | Increased | 5 | 8.2 | IL-2 | Increased | 28 | 45.9 | IL-6 | Increased | 23 | 37.7 | IL-8 | Increased | 15 | 24.6 | IL-10 | Increased | 12 | 19.7 | NTF | Increased | 22 | 36.1 |
|
|